[go: up one dir, main page]

DE602006017256D1 - Arylessigsäure- und esterderivate und deren verwendung als entzündungshemmende mittel - Google Patents

Arylessigsäure- und esterderivate und deren verwendung als entzündungshemmende mittel

Info

Publication number
DE602006017256D1
DE602006017256D1 DE602006017256T DE602006017256T DE602006017256D1 DE 602006017256 D1 DE602006017256 D1 DE 602006017256D1 DE 602006017256 T DE602006017256 T DE 602006017256T DE 602006017256 T DE602006017256 T DE 602006017256T DE 602006017256 D1 DE602006017256 D1 DE 602006017256D1
Authority
DE
Germany
Prior art keywords
inflammatory agents
ester derivatives
arylic acid
arylic
acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
DE602006017256T
Other languages
English (en)
Inventor
Lyndon Nigel Brown
Catherine Leblanc
David Andrew Sandham
Harinder Pal Singh
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis AG
Original Assignee
Novartis AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis AG filed Critical Novartis AG
Publication of DE602006017256D1 publication Critical patent/DE602006017256D1/de
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Pulmonology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Immunology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DE602006017256T 2005-12-09 2006-12-07 Arylessigsäure- und esterderivate und deren verwendung als entzündungshemmende mittel Active DE602006017256D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0525144.2A GB0525144D0 (en) 2005-12-09 2005-12-09 Organic compounds
PCT/EP2006/011770 WO2007065683A1 (en) 2005-12-09 2006-12-07 Aryl acetic acid and ester derivatives and their uses as antiinflammatory

Publications (1)

Publication Number Publication Date
DE602006017256D1 true DE602006017256D1 (de) 2010-11-11

Family

ID=35735863

Family Applications (1)

Application Number Title Priority Date Filing Date
DE602006017256T Active DE602006017256D1 (de) 2005-12-09 2006-12-07 Arylessigsäure- und esterderivate und deren verwendung als entzündungshemmende mittel

Country Status (17)

Country Link
US (1) US20080312229A1 (de)
EP (1) EP1960398B1 (de)
JP (1) JP2009518343A (de)
KR (1) KR20080065699A (de)
CN (1) CN101326185A (de)
AR (1) AR056887A1 (de)
AT (1) ATE482957T1 (de)
AU (1) AU2006322206B2 (de)
BR (1) BRPI0619529A2 (de)
CA (1) CA2630611A1 (de)
DE (1) DE602006017256D1 (de)
GB (1) GB0525144D0 (de)
PE (1) PE20071035A1 (de)
PT (1) PT1960398E (de)
RU (1) RU2008127439A (de)
TW (1) TW200732337A (de)
WO (1) WO2007065683A1 (de)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MY144903A (en) * 2004-06-17 2011-11-30 Novartis Ag Pyrrolopyridine derivatives and their use as crth2 antagonists
GB0525143D0 (en) * 2005-12-09 2006-01-18 Novartis Ag Organic compounds
NZ574705A (en) 2006-08-07 2011-12-22 Actelion Pharmaceuticals Ltd (3-amino-1,2,3,4-tetrahydro-9h-carbazol-9-yl)-acetic acid derivatives
US8563573B2 (en) 2007-11-02 2013-10-22 Vertex Pharmaceuticals Incorporated Azaindole derivatives as CFTR modulators
WO2009093029A1 (en) * 2008-01-22 2009-07-30 Oxagen Limited Compounds having crth2 antagonist activity
HRP20150898T1 (hr) * 2010-01-27 2015-10-09 Boehringer Ingelheim International Gmbh Spojevi pirazola kao antagonisti crth2
EP2558447B1 (de) 2010-03-22 2014-09-17 Actelion Pharmaceuticals Ltd. 3-(heteroaryl-amino-)1,2,3,4-tetrahydro-9h-carbazol-derivate und ihre verwendung als prostaglandin-d2-rezeptormodulatoren
US8802868B2 (en) 2010-03-25 2014-08-12 Vertex Pharmaceuticals Incorporated Solid forms of (R)-1(2,2-difluorobenzo[D][1,3]dioxo1-5-yl)-N-(1-(2,3-dihydroxypropyl-6-fluoro-2-(1-hydroxy-2-methylpropan2-yl)-1H-Indol-5-yl)-Cyclopropanecarboxamide
JP2013525371A (ja) 2010-04-22 2013-06-20 バーテックス ファーマシューティカルズ インコーポレイテッド シクロアルキルカルボキサミド−インドール化合物の製造方法
EP2457900A1 (de) 2010-11-25 2012-05-30 Almirall, S.A. Neue Pyrazolderivate mit CRTH2-antagonistischem Verhalten
MX338516B (es) 2011-04-14 2016-04-20 Actelion Pharmaceuticals Ltd Derivados de acido 7- (heteroaril-amino) -6, 7, 8, 9- tetrahidropirido[1,2-a] indol acetico y sus usos como modulador del receptor de prostaglandina.
SI2781508T1 (sl) * 2011-11-17 2019-03-29 Kbp Biosciences Co., Ltd. Zlite obročne spojine, ki vsebujejo dušik za uporabo kot antagonisti CRTH2
KR101864060B1 (ko) 2014-03-17 2018-06-01 이도르시아 파마슈티컬스 리미티드 아자인돌 아세트산 유도체 및 프로스타글란딘 ｄ2 수용체 조절제로서의 그의 용도
AU2015233046A1 (en) 2014-03-18 2016-11-03 Idorsia Pharmaceuticals Ltd Azaindole acetic acid derivatives and their use as prostaglandin D2 receptor modulators
HUE039062T2 (hu) 2014-04-15 2018-12-28 Vertex Pharma Gyógyszerészeti készítmények cisztás fibrózis transzmembrán konduktancia regulátor által mediált betegségek kezelésére
KR20180053345A (ko) 2015-09-15 2018-05-21 이도르시아 파마슈티컬스 리미티드 결정질 형태
BR112020009055A2 (pt) 2017-11-06 2020-11-03 Rapt Therapeutics, Inc. moduladores de receptor de quimiocina para tratamento de câncer positivo para vírus epstein barr

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3320268A (en) * 1964-08-14 1967-05-16 Merck & Co Inc 1-aroyl or heteroaroyl-7-azaindole-3-carboxylates and derivatives
PT1590314E (pt) * 2003-02-06 2015-11-19 Dompã Farmaceutici S P A Ácidos 2-aril-acéticos, seus derivados e composições farmacêuticas que os contêm
MY144903A (en) * 2004-06-17 2011-11-30 Novartis Ag Pyrrolopyridine derivatives and their use as crth2 antagonists

Also Published As

Publication number Publication date
BRPI0619529A2 (pt) 2011-10-04
CN101326185A (zh) 2008-12-17
WO2007065683A1 (en) 2007-06-14
PT1960398E (pt) 2010-11-26
AU2006322206A1 (en) 2007-06-14
AU2006322206B2 (en) 2010-08-19
EP1960398B1 (de) 2010-09-29
TW200732337A (en) 2007-09-01
ATE482957T1 (de) 2010-10-15
GB0525144D0 (en) 2006-01-18
JP2009518343A (ja) 2009-05-07
EP1960398A1 (de) 2008-08-27
KR20080065699A (ko) 2008-07-14
US20080312229A1 (en) 2008-12-18
AR056887A1 (es) 2007-10-31
CA2630611A1 (en) 2007-06-14
PE20071035A1 (es) 2007-10-30
RU2008127439A (ru) 2010-01-20

Similar Documents

Publication Publication Date Title
DE602005013491D1 (de) Benzamidderivate und deren verwendung als glucokinaseaktivierende mittel
DE602006017256D1 (de) Arylessigsäure- und esterderivate und deren verwendung als entzündungshemmende mittel
ATE378338T1 (de) Pyrrolopyridinderivate und deren verwendung als crth2-antagonisten
EP2131848A4 (de) Zusammensetzungen und verfahren für verstärkte aktivität von biologisch aktiven molekülen
ATE472546T1 (de) 5-heteroarylthiazole und deren verwendung als pi3k-inhibitoren
ATE553096T1 (de) Pyridazinderivate und ihre verwendung als therapeutische wirkstoffe
DE60332023D1 (de) Chinolinderivate und deren verwendung als mycobakterielle inhibitoren
DE60309856D1 (de) Substituierte phenylacetamide und deren verwendung als glucokinaseaktivatoren
DE602005015699D1 (de) Prolinderivate und deren verwendung als dipeptidylpeptidase-iv-inhibitoren
ATE472543T1 (de) Heteroaromatische chinolinverbindungen und deren verwendung als pde10-inhibitoren
DE60321043D1 (de) Biphenylderivate und deren verwendung als fungizide
ATE444068T1 (de) Chinolinderivate und ihre verwendung als mycobakterielle inhibitoren
DE602004021904D1 (de) Gyraseinhibitoren und deren verwendungen
ATE517081T1 (de) Hydroxamsäureester und deren pharmazeutische verwendung
DE60233825D1 (de) BENZOATESÄURE-2-(a-HYDROXYPENTYL)ESTER UND DESSEN HERSTELLUNG UND VERWENDUNG
DE602005004144D1 (de) Octahydropyrroloä3,4-cüpyrrolderivate und deren verwendung als antivirale mitteln
ATE519744T1 (de) 1h-pyrazol-4-carbonsäure-amide, deren herstellung und verwendung als 11-beta-hydroxysteroid- dehydrogenase-hemmer
DE602006012060D1 (de) Bicyclische bisamidderivate und deren anwendung als insektizide
DE502007001209D1 (de) Wachszusammensetzung und deren Verwendung
DE602004028700D1 (de) Kosmetische Zusammensetzungen und deren Verwendung
ATE511507T1 (de) Piperidinylcarbonylpyrrolidine und deren verwendung als melanocortinagonisten
DE602005009988D1 (de) Härtbare Zusammensetzung und deren Verwendung
DE602007006540D1 (de) Cyclopropancarboxylate und deren verwendung als pestizide
ATE396185T1 (de) Substituierte 4-alkyl- und 4- alkanoylpiperidinderivate und deren verwendung als neurokininantagonisten
DE602004008668D1 (de) Benzoxazinderivate und deren verwendungen

Legal Events

Date Code Title Description
R097 No opposition filed against granted patent, or epo opposition proceedings concluded without decision

Ref document number: 1960398

Country of ref document: EP

Effective date: 20110630

R082 Change of representative

Ref document number: 1960398

Country of ref document: EP

Representative=s name: DR. SCHOEN & PARTNER, 80336 MUENCHEN, DE